World Pharmaceutical Market (2007)

Published by: RNCOS

Published: Nov. 1, 2006 - 75 Pages

Table of Contents

1. Analyst View

2. Research Overview

3. Industry Overview

3.1 Worldwide Therapeutic Segmentation in the Pharmaceutical Market

3.2 Worldwide Pharmaceutical Market Segmentation by Region

3.3 Worldwide Expenditure on Pharmaceutical Drugs

3.4 Worldwide Emerging Markets in Pharmaceutical Industry

4. Industry Performance

4.1 By Vendors

4.2 By Therapy Classes and Products

4.2.1 Therapy Classes

4.2.2 Product Classes

4.2.2.1 Biologics Market

4.2.2.2 Block Buster Products

4.2.2.3 Over the Counter Products (OTC)

4.3 By Geographical Spread

4.3.1 Asia-Pacific

4.3.1.1 India

4.3.1.2 China

4.3.1.3 Australia

4.3.1.4 Japan

4.3.1.5 Indonesia

4.3.1.6 Hong Kong

4.3.1.7 South Korea

4.3.2 Europe

4.3.2.1 United Kingdom

4.3.2.2 France

4.3.2.3 Germany

4.3.3 Latin America

4.3.3.1 Mexico

4.3.3.2 Brazil

4.3.3.3 Chile

4.3.4 North America

4.3.4.1 United States of America

4.3.4.2 Canada

4.3.5 Africa

4.3.5.1 South Africa

4.3.5.2 Egypt

4.3.5.3 Saudi Arabia

5. Key Driving Forces

6. Opportunities and Challenges

7. Future Outlook, 2010

8. Key Players

8.1 GlaxoSmithKline

8.2 AstraZeneca

8.3 Johnson & Johnson

8.4 Roche

8.5 Merck & Co.

8.6 Novartis

8.7 Wyeth

8.8 Bristol-Myers Squibb

8.9 Ranbaxy Laboratories Ltd.

List of Figures:

Figure 3-1: Worldwide - Pharmaceutical Market Revenue (in Billion US$), 2001-2005

Figure 3-2: Worldwide - Pharmaceutical Market by Therapeutic Segmentation (%), 2004

Figure 3-3: Worldwide - Pharmaceutical Market Segment by Region (%), 2004

Figure 3-4: Worldwide - Annual Pharmaceutical Expenditure/Head by Country (in US$), 2003

Figure 4-1: Worldwide - Growth in Biologics Market (in Billion US$), 2004 & 2005

Figure 4-2: Worldwide - Over the Counter Products Sales (in Billion US$), 2001-2005

Figure 4-3: India - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-4: China - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-5: China - Population Aged above 65 Years (%), 2006-2011

Figure 4-6: China - GDP Growth (in Trillion US$), 2001-2011E

Figure 4-7: Australia - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-8: Australia - Pharmaceutical Expenditure by Government (in Billion Aus$), 2001-2003

Figure 4-9: Japan - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-10: Indonesia - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-11: Hong Kong - Pharmaceutical Sales Market (in Million US$), 2000-2005

Figure 4-12: South Korea - Pharmaceutical Market Revenue (in Billion US$), 2001-2005

Figure 4-13: United Kingdom - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-14: France - Generic Drugs Sale (in Million US$), 2000-2004

Figure 4-15: France - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-16: Germany - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-17: Germany - Increase in Life Expectancy (in Year), 2006-2010

Figure 4-18: Germany - Forecast of Pharmaceutical Sales (in Billion US$), 2006-2010

Figure 4-19: Mexico - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-20: Brazil - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-21: Chile - Pharmaceutical Sales Market (in Million US$), 2001-2005

Figure 4-22: USA - Pharmaceutical Sales Market (in Billion US$), 2001-2005

Figure 4-23: USA - Forecast of Clinical Trial Business (in Billion US$), 2006-2011

Figure 4-24: Canada - Pharmaceutical Sales Market (in Billion US$), 2000-2005

Figure 4-25: South Africa - Pharmaceutical Market Revenue (in Billion US$), 2001-2005

Figure 5-1: Worldwide - Average Life Expectancy (in Year), 2001-2005

Figure 5-2: Worldwide - Annual Spending in Healthcare (in US$/Head), 2001-2005

Figure 5-3: Worldwide - Number of Block Buster Drugs (2000 & 2005)

Figure 5-4: Worldwide - Growth in Over the Counter Drugs Sale (in Billion US$), 2004 & 2005

Figure 6-1: Worldwide - Forecast of Clinical Trial Market (in Billion US$), 2006 & 2007

Figure 6-2: Worldwide - Forecast for Enzyme Inhibitor Market (in Billion US$), 2006-2011

Figure 6-3: Worldwide - Forecast for Plant Derived Drugs & Applications Market (in Billion US$), 2006-2011

Figure 6-4: Worldwide - Growth in Plant Derived Drugs Sale (in Billion US$), 2005, 2006 & 2011

Figure 6-5: Worldwide - Growth of Influenza Therapeutics Market (in Billion US$), 2006-2010

Figure 6-6: Worldwide - Growth of Pharmacogenomics Market (in Billion US$), 2006-2009

Figure 6-7: Worldwide - Growth of Contract Manufacturing (in Billion US$), 2006-2009

Figure 6-8: Worldwide - Anti-infective Market (in Billion US$), 2006-2010

Figure 7-1: Worldwide - Forecast of Pharmaceutical Market (in Billion US$), 2006-2010

Figure 7-2: Worldwide - Application Market for RFID Technology in Pharmaceutical Industry (in Billion US$), 2006-2011

Figure 8-1: GlaxoSmithKline - Stock Performance

Figure 8-2: AstraZeneca - Stock Performance

Figure 8-3: Johnson & Johnson - Stock Performance

Figure 8-4: Roche - Stock Performance

Figure 8-5: Merck & Co. - Stock Performance

Figure 8-6: Norvatis - Stock Performance

Figure 8-7: Wyeth - Stock Performance

Figure 8-8: Bristol-Myers Squibb - Stock Performance

Figure 8-9: Ranbaxy Laboratories Ltd. - Stock Performance

List of Tables:

Table 4-1: Worldwide - Pharmaceutical Sales by Top 10 Vendors (in Billion US$), 2005

Table 4-2: Worldwide - Pharmaceutical Sales by Major Therapy Classes (in Billion US$), 2005

Table 4-3: Worldwide - Pharmaceutical Sales by Leading Product Category (in Billion US$), 2005

Table 4-4: Worldwide - Over the Counter Drugs Sale by Therapy Classes (in Billion US$), 2005

Table 4-5: Worldwide - Over the Counter Drugs Market by Company (in Billion US$), 2005

Table 8-1: GlaxoSmithKline - Key Financial Overview (in Million US$), 2001-2005

Table 8-2: AstraZeneca - Key Financial Overview (in Million US$), 2005 & 2006

Table 8-3: Johnson & Johnson - Key Financial Overview (in Million US$), 2003-2005

Table 8-4: Roche - Key Financial Overview (in Million US$), 2005

Table 8-5: Merck & Co. - Key Financial Overview (in Million US$), 2003-2005

Table 8-6: Novartis - Key Financial Overview (in Million US$), 2001-2005

Table 8-7: Wyeth - Key Financial Overview (in Million US$), 2001-2005

Table 8-8: Bristol-Myers Squibb - Key Financial Overview (in Million US$), 2001-2005

Table 8-9: Ranbaxy Laboratories Ltd. - Key Financial Overview (in Million US$), 2002-2004

Abstract

• The global Pharmaceuticals Market has demonstrated consistent strong growth patterns in the last five years generating total revenues of US$ 534.8 Billion in 2005.
• Much of the growth in the Global Pharmaceutical industry can be attributed to the change in the disease profile of the global population. Increasing incidence of lifestyle related diseases have led to an increase in demand for drugs for these particular categories.
• North America remains the largest Pharmaceutical market constituting 49% of the worldwide market followed by Europe and Asia-Pacific.
• Pharmaceutical market across the world is witnessing increased opportunities in the area of Bio Pharmaceuticals, Pharmacogenomics and Biologics market.
• The smaller national markets in Asia-Pacific and Latin America are expected to grow significantly and will increase their presence in the global Pharmaceutical landscape.

• What are the emerging trends in the Global Pharmaceutical sector?
• What are the future prospects of the Pharmaceutical industry in various regions across the world?
• Who are the Key players in the Pharmaceutical market?
• What opportunities exist in the Pharmaceutical market?
• What Challenges are being faced by the industry?

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.